Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Covetrus stock

Learn how to easily invest in Covetrus stock.

Covetrus Inc
- $0.23 ( - 1.39%)

Covetrus Inc is a health information services business based in the US. Covetrus shares (CVET) are listed on the NASDAQ and all prices are listed in US Dollars. Covetrus employs 5,275 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Covetrus

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CVET – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Covetrus stock price (NASDAQ: CVET)

Use our graph to track the performance of CVET stocks over time.

Covetrus shares at a glance

Information last updated 2022-01-10.
Latest market close$16.27
52-week range$16.62 - $40.78
50-day moving average $18.57
200-day moving average $23.23
Wall St. target price$26.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.41

Buy Covetrus shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stocks, Options, ETFs
$0 per year
Get a free stock valued up to $3500
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
$125 - $625
Open and fund an account with $25,000 - $250,000+

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Covetrus stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Covetrus price performance over time

Historical closes compared with the close of $16.27 from 2022-01-14

1 week (2022-01-10) -7.56%
1 month (2021-12-17) -9.91%
3 months (2021-10-15) -18.16%
6 months (2021-07-16) -32.49%
1 year (2021-01-15) -55.88%
2 years (2020-01-16) 9.05%
3 years (2019-01-13) N/A
5 years (2017-01-13) N/A

Is Covetrus stock undervalued or overvalued?

Valuing Covetrus stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Covetrus's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Covetrus's PEG ratio

Covetrus's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.3326. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Covetrus's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Covetrus's EBITDA

Covetrus's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $158 million.

The EBITDA is a measure of a Covetrus's overall financial performance and is widely used to measure a its profitability.

Covetrus financials

Revenue TTM $4.6 billion
Gross profit TTM $798 million
Return on assets TTM -0.22%
Return on equity TTM -3.55%
Profit margin -1.2%
Book value $10.91
Market capitalisation $2.4 billion

TTM: trailing 12 months

Covetrus share dividends

We're not expecting Covetrus to pay a dividend over the next 12 months.

Covetrus share price volatility

Over the last 12 months, Covetrus's shares have ranged in value from as little as $16.623 up to $40.775. A popular way to gauge a stock's volatility is its "beta".

CVET.US volatility(beta: 2.11)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Covetrus's is 2.1112. This would suggest that Covetrus's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Covetrus overview

Covetrus, Inc. , together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions that include, inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific.

Frequently asked questions

What percentage of Covetrus is owned by insiders or institutions?
Currently 0.398% of Covetrus shares are held by insiders and 96.775% by institutions.
How many people work for Covetrus?
Latest data suggests 5,275 work at Covetrus.
When does the fiscal year end for Covetrus?
Covetrus's fiscal year ends in December.
Where is Covetrus based?
Covetrus's address is: 7 Custom House Street, Portland, ME, United States, 04101
What is Covetrus's ISIN number?
Covetrus's international securities identification number is: US22304C1009
What is Covetrus's CUSIP number?
Covetrus's Committee on Uniform Securities Identification Procedures number is: 22304C100

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site